President and Chief Executive Officer
Adam is a certified medical doctor and holds a Doctor of Medical Sciences degree (D.M.Sc./dr.med.) from the University of Copenhagen, Denmark, and an MBA from IMD, Switzerland. Adam has published more than 45 peer-reviewed scientific papers in renowned international journals.
Prior to joining Zealand, Adam led clinical research teams as medical director at Novo Nordisk and worked as a clinician at Rigshospitalet, University of Copenhagen. Adam was a medical and scientific advisor in the areas of endocrinology, cardiology, gastroenterology and rheumatology, and has significant experience of leading regulatory strategies.
Adam is a board member of the board of directors of Cessatech ApS and a board observer of Beta Bionics, Inc.
Christina Sonnenborg Bredal
Senior Vice President and Global Head of People & Organization
Christina holds a Master of Law from the University of Copenhagen and is an educated attorney with admission to practice law.
Most recently, Christina was a consultant in PwC Legal, specializing in employment law and employee share programs. Previously, Christina worked at EY, People Advisory Services, specializing in global mobility tax and rewards.
Christina has also worked as a trial lawyer litigating civil court cases and as an attorney specializing in M&A and legal due diligence.
Chief Medical Officer
David is a physician trained in diabetes, endocrinology and metabolism. He holds a Doctor of Medicine from the University of Minnesota and a Bachelor of Arts in Biology from St. Olaf College.
David has served as Chief Medical Officer for MannKind Corporation, VP – Medical Affairs and Distinguished Medical Fellow at Eli Lilly and Company and as Chief Scientific and Medical Officer for the American Diabetes Association. His clinical career includes roles as both Chief of Clinical Services and Medical Director at the International Diabetes Center and as faculty at the University of Minnesota.
Chief Financial Officer
Henriette holds a Master’s degree in Finance and Strategic Management and a Bachelor’s degree in Business Administration and Management from Copenhagen Business School.
Prior to joining Zealand, Henriette served as the Vice President and Head of Investor Relations and Treasury at GN Store Nord, a global leader in intelligent audio solutions listed on the Nasdaq Copenhagen. Prior to that role, she was Vice President and Head of Global Finance at GN Hearing. Henriette began her career with Novo Nordisk, rising through financial leadership roles.
Executive Vice President and Chief Operating Officer
Ivan holds a Master of Science in Chemical Engineering from the Technical University of Denmark (DTU) and a Master of Business Administration from Harvard Business School.
Prior to joining Zealand, Ivan worked for Novartis in both generics and pharmaceutical manufacturing, as well as in strategy, quality assurance, contract manufacturing and supply chain leadership in Germany, the U.S. and Switzerland.
Ivan was project leader at The Boston Consulting Group in the pharmaceutical R&D and manufacturing areas.
Senior Vice President and General Counsel
Ravinder holds a BSc in Pharmacology from the University of Leeds. He qualified as a Barrister and then qualified as Solicitor(England & Wales). In addition, he holds Postgraduate Diplomas in Competition Law (King’s College, London) and Intellectual Property Law (Bristol). He also holds an executive MBA from Copenhagen Business School.
Ravinder brings international experience in intellectual property law in the life science sector, with expertise in litigation, licensing, mergers, acquisitions. Additionally, he has experience with financing, securitization, and capital markets. Prior to his in-house roles as Director of Intellectual Property at Polpharma SA and Actavis Group Hf, he worked for 10 years in private practice in London, practicing contentious and non-contentious intellectual property law.